240 likes | 549 Vues
EFFECT OF AUTOFLORESCENT BRONCHOSCOPY TO DETECTING NEW CANCER OR PREMALIGN LESION IN PATIENTS OPERATED DUE TO LUNG CANCER. Nurdan Kalkan, Gülşah Günlüoğlu, Sedat Altın, Erdoğan Çetinkaya, Nurdan Şimşek Yedikule Chest Diseases and Thoracic Surgery Center. Lung cancer. Early diagnosis
E N D
EFFECT OF AUTOFLORESCENT BRONCHOSCOPY TO DETECTING NEW CANCER OR PREMALIGN LESION IN PATIENTS OPERATED DUE TO LUNG CANCER Nurdan Kalkan, Gülşah Günlüoğlu, Sedat Altın, Erdoğan Çetinkaya, Nurdan Şimşek Yedikule Chest Diseases and Thoracic Surgery Center
Lung cancer • Early diagnosis • Endobronchial therapy • Better survival
Early diagnosis • Molecular genetic abnormalities, • Metaplasia, • Displasia, • CIS, • İnvasive carcinoma
Çok erken tanı • Sputum cytology Invasive carcinoma • Radiographs • Bronchoscopy Premalign lesion
White Light Bronchoscopy(WLB) • Nodular, polypoid 2mm • Mucosal >5mm • CIS under basal membran in 75% of patients
Autoflorescent Bronchoscopy(AFB) Light on normal mucosa • Reflection • Absorbtion can seen • Dispersion • Florescence can not seen
Florescence • Structural elements of tissue (collogen, elastin) • Cellular metabolites (NADH, flavines) • Aromatic aminoacides, porfirines, lipopigments • Decreases at pathologic tissue
Florescence • Potentialisation of the florescence ( with hematoporfirine derives) • Detecting autoflorescence
Autoflorescence • The rate of detected premalign lesion is more than with white light • (Venmans, Lam, O’Neill..)
Study • In operated patients due to lung cancer (who encountered with carcinogens) • To detecting existence of premalign lesion (no invasive carcinoma) • Effect of AFB when compared with WLB
Patients • 40 patients operated on due to lung cancer • 39 male, 1 female, with mean age of 58,1 • Cigarette 57 p.p. year • 8 ex-smoker
Procedure • At same session • Experienced bronchoscopyst • Biopsies from bronchial stump in all patients(40) • Biopsies from other pathological seen areas • Histopathological examination • Comparing sensitivities and spesivicities of WLB and AFB
Patients • 31% epidermoid carcinoma • 72,5% lobectomy • 42% stage 2 • 17,5% stage 3A • 37,5% adjuvant therapy • Mean time between surgery and bronchoscopy is 21,4 month
WLB: 2 pathologic areas 2 cancer AFB: 6 pathologic areas 2 cancer, 4 normal Bronchial stump areas Pathologic exam: 5 pathologic areas 2 cancer, 3 metaplasia
WLB: Sensitivity: 40% FP:0 AFB: Sensitivity:40% FP:66% Bronchial stump areas
WLB: 2 pathologic areas: 1 cancer, 1 metaplasia 1 low grade, 1 high grade AFB: 8 pathologic areas: 1 cancer 1 high displasia, 3 metaplasia, 3 normal 3 low grade, 2 high grade Areas other than bronchial stump
WLB: Sensitivity:40% FP:0 AFB: Sensitivity:100% FP:37% Areas other than bronchial stump Relative sensitivity of AFB is more than WLB 2,5 times
WLB: Sensitivity:40% FP:0 AFB: Sensitivity:70% FP:50% All biopsies Relative sensitivity of AFB is more than WLB 1,75 times
Low grade lesions (metaplasia, low grade displasia) • Sensitivity of WLB: 17%(1/6) • Sensitivity of AFB : 50%(3/6) • Relative sensitivity of AFB is more than WLB 2,94 times
Yüksek grade (moderate and high grade displasia, CIS, carcinoma) • Sensitivity of WLB: %75 (3/4) • Sensitivity of AFB : %100 (4/4) Relative sensitivity of AFB is more than WLB 1,33 times • Number of patients, number of invasive carcinomas
Other results • There is no effect of tumor type on developing new lesion • There is no effect of surgical procedure type on developing new lesion • There is no effect of continue to smoking on developing new lesion • AFB could detect all lesions detected by WLB
False positivity of AFB • İnflammation, • Effect of surgery on bronchial stump areas, • İndividual degree of florophores on normal mucosa, • Bronchoscopist and patholog factors, • Molecular carcinonogenesis • Reported 1/3 • Have not bad effect except need of additional biopsy
False negativity of AFB • Changes secondary to surgery • Folding of mucosa • Longutidunal swelling of membranous side may hide small lesions • Bronchoscopist and patholog factors
Conclusion • SENSITIVITY OF AFB IS MORE THAN WLB TO DIAGNOSING NEW CANCER OR PREMALIGN LESIONS IN OPERATED NSCLC PATIENTS